Transaction · 0001104659-26-104739

Sherman Darren

Sherman Darren, SR, reported an open-market or private sale at Orchestra BioMed Holdings, Inc. involving 15000.000000 shares for an estimated $74100.00. Reported holdings after the transaction were 1134402.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
OBIOOrchestra BioMed Holdings, Inc.
Filing timeSep 02
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$4.95
Pre-filing
1mo ago -19.6%1w ago +9.3%1d ago +1.8%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

OBIO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OBIO since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001104659-26-104739
Common Stock, par value $0.0001 per share ("Common Stock")
Transaction date
Sep 01, 2026
Filed Sep 02, 2026, 08:15 PM · 1d delay
Shares
15.0k sh
$494 per share
Estimated value
-$7.41M
Computed from shares × price
Holdings after
1.13M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025.

  2. F2

    The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any…

  3. F3

    The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purpo…

Original filing · 0001104659-26-104739
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OBIO